Home › Trial NCT02348450
Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer
- Trial IDNCT02348450
- StatusUnknown
- PhasePhase 4
- Study typeInterventional
- SponsorGuangdong Association of Clinical Trials
- Enrollment308
- Start date2015-02
- ConditionsSmall Cell Lung Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.